A novel adenylyl cyclase type 5 inhibitor that reduces myocardial infarct size even when administered after coronary artery reperfusion

201813 citationsJournal Article

Authors

Good health and well-being

Published in: Journal of Molecular and Cellular Cardiology

Volume 121, pp. 13-15

Field-Weighted Citation Impact: 0.74